Agency Forms Undergoing Paperwork Reduction Act Review, 23767-23768 [2013-09363]
Download as PDF
<![CDATA[
23767
Federal Register / Vol. 78, No. 77 / Monday, April 22, 2013 / Notices
Background and Brief Description
In the past, polychlorinated biphenyls
(PCBs) were used as coolants and
lubricants in electrical equipment. They
didn’t burn easily and were good
insulators. PCBs are no longer made in
the U.S. They were banned in 1977
because they persist in the environment.
The public and the scientific
community became concerned about
harm to human health from persistent
exposure to PCBs.
The City of Anniston, AL, was the site
of the former Monsanto facility. PCBs
were made there from 1929 to 1971. For
decades, PCBs were released into the
local air, soil, and surface water. In
1996, residents found out they were
exposed. Concerns grew and led to
litigation. In 2003, a settlement in favor
of the residents was reached in state and
federal courts.
The Anniston Environmental Health
Research Consortium (AEHRC) was
funded by the Agency for Toxic
Substances and Disease Registry
(ATSDR). The AEHRC conducted the
Anniston Community Health Survey
(ACHS) from 2005 to 2007. Serum PCB
levels in 766 Anniston adults were
found to be three to seven times higher
than in U.S. adults. Also, higher PCB
levels were found in Anniston adults
who had high blood pressure and
diabetes.
ATSDR and National Institutes of
Health (NIH) plan to continue the work
of the first ACHS. These agencies will
conduct a follow-up study called the
ACHS–II. Data collection will be
managed by the University of Alabama
at Birmingham (UAB) and the Calhoun
County Health Department (CCHD).
A sample of 500 surviving ACHS
cohort members with PCBs
measurements will be enrolled in the
ACHS–II. After informed consent,
clinical assessments will be done. These
will be for blood pressure, height,
weight, hip, and body girth. A
questionnaire will be answered by
computer-assisted personal interviews
(CAPIs). Questions will be asked for
health, demographic, diet, and lifestyle
factors. The self-reported responses will
be compared to laboratory analytes. For
these, blood samples will be drawn and
analyzed.
The ACHS–II will measure the same
serum PCBs as in the first Anniston
survey. In this way, changes in PCB
levels can be studied. The ACHS–II will
also include serum analytes for dioxins,
furans, dioxin-like PCBs, and
chlorinated pesticides. Additional
analytes include blood measures of
polybrominated biphenyls and heavy
metals. Clinical biomarkers will include
measures for thyroid, diabetes, lipids,
and immune function. This will give a
more complete profile of human
exposures and health in Anniston, AL.
The ATSDR is requesting a two-year
approval for this information collection.
The total annualized burden is 227
hours.
There are no costs to respondents
other than their time. Each respondent
will spend about 2 hours in the study.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
Form name
Adults who took part in first
Anniston Community Health
Survey.
Recruitment Telephone Script ................................................
Survey for Refusals ................................................................
Update Contact Information Form ..........................................
Medications Form ...................................................................
Blood Draw Form ...................................................................
Questionnaire .........................................................................
Ron A. Otten,
Director, Office of Scientific Integrity, Office
of the Associate Director for Science, Office
of the Director, Centers for Disease Control
and Prevention.
[FR Doc. 2013–09362 Filed 4–19–13; 8:45 am]
BILLING CODE 4163–18–P
email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC 20503 or by fax to (202) 395–5806.
Written comments should be received
within 30 days of this notice.
Proposed Project
Centers for Disease Control and
Prevention
Anniston Community Health Survey:
Follow-up and Dioxin Analyses (ACHS–
II)—New—Agency for Toxic Substances
and Disease Registry (ATSDR),
Department of Health and Human
Services (DHHS).
[30Day–13–12RO]
Background and Brief Description
Agency Forms Undergoing Paperwork
Reduction Act Review
In the past, polychlorinated biphenyls
(PCBs) were used as coolants and
lubricants in electrical equipment. They
didn’t burn easily and were good
insulators. PCBs are no longer made in
the U.S. They were banned in 1977
because they persist in the environment.
The public and the scientific
community became concerned about
harm to human health from persistent
exposure to PCBs.
tkelley on DSK3SPTVN1PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call (404) 639–7570 or send an
VerDate Mar<15>2010
17:03 Apr 19, 2013
Jkt 229001
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
333
160
250
250
250
250
Number of
responses per
respondent
1
1
1
1
1
1
Average
burden per
response
(in hrs)
2/60
1/60
1/60
3/60
2/60
45/60
The City of Anniston, AL, was the site
of the former Monsanto facility. PCBs
were made there from 1929 to 1971. For
decades, PCBs were released into the
local air, soil, and surface water. In
1996, residents found out they were
exposed. Concerns grew and led to
litigation. In 2003, a settlement in favor
of the residents was reached in state and
federal courts.
The Anniston Environmental Health
Research Consortium (AEHRC) was
funded by the Agency for Toxic
Substances and Disease Registry
(ATSDR). The AEHRC conducted the
Anniston Community Health Survey
(ACHS) from 2005 to 2007. Serum PCB
levels in 766 Anniston adults were
found to be three to seven times higher
than in U.S. adults. Also, higher PCB
levels were found in Anniston adults
who had high blood pressure and
diabetes.
ATSDR and National Institutes of
Health (NIH) plan to continue the work
of the first ACHS. These agencies will
conduct a follow-up study called the
E:\FR\FM\22APN1.SGM
22APN1
23768
Federal Register / Vol. 78, No. 77 / Monday, April 22, 2013 / Notices
ACHS–II. Data collection will be
managed by the University of Alabama
at Birmingham (UAB) and the Calhoun
County Health Department (CCHD).
A sample of 500 surviving ACHS
cohort members with PCBs
measurements will be enrolled in the
ACHS–II. After informed consent,
clinical assessments will be done. These
will be for blood pressure, height,
weight, hip, and body girth. A
questionnaire will be answered by
computer-assisted personal interviews
(CAPIs). Questions will be asked for
health, demographic, diet, and lifestyle
factors. The self-reported responses will
be compared to laboratory analytes. For
these, blood samples will be drawn and
analyzed.
The ACHS–II will measure the same
serum PCBs as in the first Anniston
survey. In this way, changes in PCB
levels can be studied. The ACHS–II will
also include serum analytes for dioxins,
furans, dioxin-like PCBs, and
chlorinated pesticides. Additional
analytes include blood measures of
polybrominated biphenyls and heavy
metals. Clinical biomarkers will include
measures for thyroid, diabetes, lipids,
and immune function. This will give a
more complete profile of human
exposures and health in Anniston, AL.
The ATSDR is requesting a two-year
approval for this information collection.
The total annualized burden is 227
hours.
There are no costs to respondents
other than their time. Each respondent
will spend about 2 hours in the study.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
Form name
Adults who took part in first Anniston Community Health Survey.
Recruitment Telephone Script .......................
Survey for Refusals ........................................
Update Contact Information Form .................
Medications Form ...........................................
Blood Draw Form ...........................................
Questionnaire .................................................
Ron A. Otten,
Director, Office of Scientific Integrity, Office
of the Associate Director for Science, Office
of the Director, Centers for Disease Control
and Prevention.
[FR Doc. 2013–09363 Filed 4–19–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
tkelley on DSK3SPTVN1PROD with NOTICES
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Developing Research Capacity
to Assess Health Effects Associated with
Volcanic Emissions and other
Environmental Exposures, Funding
Opportunity Announcement (FOA)
EH13–002, Initial Review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned SEP:
Time and Date: 1:00 p.m.–4:00 p.m.,
June 18, 2013 (Closed).
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
Management Analysis and Services
VerDate Mar<15>2010
17:03 Apr 19, 2013
Jkt 229001
Office, CDC, pursuant to Public Law 92–
463.
Matters to be Discussed: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Developing Research Capacity to
Assess Health Effects Associated with
Volcanic Emissions and other
Environmental Exposures, FOA EH–13–
002’’.
Contact Person for More Information:
J. Felix Rogers, Ph.D., M.P.H., Scientific
Review Officer, CDC, 4770 Buford
Highway, NE., Mailstop F63, Atlanta,
Georgia 30341, Telephone: (770) 488–
4334.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign FEDERAL REGISTER
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2013–09403 Filed 4–19–13; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
333
160
250
250
250
250
Number of
responses per
respondent
Average
burden per
response
(in hrs)
1
1
1
1
1
1
2/60
1/60
1/60
3/60
2/60
45/60
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifiers CMS–10151]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, HHS.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
Services (CMS) is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
1. Type of Information Collection
Request: Reinstatement with change of a
previously approved collection; Title of
Information Collection: Data Collection
AGENCY:
E:\FR\FM\22APN1.SGM
22APN1
]]>Agencies
[Federal Register Volume 78, Number 77 (Monday, April 22, 2013)]
[Notices]
[Pages 23767-23768]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-09363]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-13-12RO]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
(404) 639-7570 or send an email to omb@cdc.gov. Send written comments
to CDC Desk Officer, Office of Management and Budget, Washington, DC
20503 or by fax to (202) 395-5806. Written comments should be received
within 30 days of this notice.
Proposed Project
Anniston Community Health Survey: Follow-up and Dioxin Analyses
(ACHS-II)--New--Agency for Toxic Substances and Disease Registry
(ATSDR), Department of Health and Human Services (DHHS).
Background and Brief Description
In the past, polychlorinated biphenyls (PCBs) were used as coolants
and lubricants in electrical equipment. They didn't burn easily and
were good insulators. PCBs are no longer made in the U.S. They were
banned in 1977 because they persist in the environment. The public and
the scientific community became concerned about harm to human health
from persistent exposure to PCBs.
The City of Anniston, AL, was the site of the former Monsanto
facility. PCBs were made there from 1929 to 1971. For decades, PCBs
were released into the local air, soil, and surface water. In 1996,
residents found out they were exposed. Concerns grew and led to
litigation. In 2003, a settlement in favor of the residents was reached
in state and federal courts.
The Anniston Environmental Health Research Consortium (AEHRC) was
funded by the Agency for Toxic Substances and Disease Registry (ATSDR).
The AEHRC conducted the Anniston Community Health Survey (ACHS) from
2005 to 2007. Serum PCB levels in 766 Anniston adults were found to be
three to seven times higher than in U.S. adults. Also, higher PCB
levels were found in Anniston adults who had high blood pressure and
diabetes.
ATSDR and National Institutes of Health (NIH) plan to continue the
work of the first ACHS. These agencies will conduct a follow-up study
called the
[[Page 23768]]
ACHS-II. Data collection will be managed by the University of Alabama
at Birmingham (UAB) and the Calhoun County Health Department (CCHD).
A sample of 500 surviving ACHS cohort members with PCBs
measurements will be enrolled in the ACHS-II. After informed consent,
clinical assessments will be done. These will be for blood pressure,
height, weight, hip, and body girth. A questionnaire will be answered
by computer-assisted personal interviews (CAPIs). Questions will be
asked for health, demographic, diet, and lifestyle factors. The self-
reported responses will be compared to laboratory analytes. For these,
blood samples will be drawn and analyzed.
The ACHS-II will measure the same serum PCBs as in the first
Anniston survey. In this way, changes in PCB levels can be studied. The
ACHS-II will also include serum analytes for dioxins, furans, dioxin-
like PCBs, and chlorinated pesticides. Additional analytes include
blood measures of polybrominated biphenyls and heavy metals. Clinical
biomarkers will include measures for thyroid, diabetes, lipids, and
immune function. This will give a more complete profile of human
exposures and health in Anniston, AL.
The ATSDR is requesting a two-year approval for this information
collection. The total annualized burden is 227 hours.
There are no costs to respondents other than their time. Each
respondent will spend about 2 hours in the study.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondents Form name respondents responses per response (in
respondent hrs)
----------------------------------------------------------------------------------------------------------------
Adults who took part in first Anniston Recruitment Telephone 333 1 2/60
Community Health Survey. Script. 160 1 1/60
Survey for Refusals..... 250 1 1/60
Update Contact
Information Form.
Medications Form........ 250 1 3/60
Blood Draw Form......... 250 1 2/60
Questionnaire........... 250 1 45/60
----------------------------------------------------------------------------------------------------------------
Ron A. Otten,
Director, Office of Scientific Integrity, Office of the Associate
Director for Science, Office of the Director, Centers for Disease
Control and Prevention.
[FR Doc. 2013-09363 Filed 4-19-13; 8:45 am]
BILLING CODE 4163-18-P
